Athira Pharma, Inc. (NASDAQ: ATHA), a clinical-stage biopharmaceutical company dedicated to the development of novel therapeutics for diseases with high unmet medical needs, today announced that it ...
11h
Athira Pharma, Inc.: Athira Pharma Announces Name Change to LeonaBio, Inc. with New Ticker "LONA"
Athira Pharma, Inc. (NASDAQ: ATHA), a clinical-stage biopharmaceutical company dedicated to the development of novel therapeutics for diseases with high ...
Fernando Mendoza prominently mentioned his mother in his Heisman Trophy acceptance speech. Here's what you should know about ...
MS is currently treated with 'disease-modifying' medicines (e.g. interferon beta, glatiramer acetate, natalizumab, fingolimod, alemtuzumab, teriflunomide, and dimethyl fumarate). These medicines can ...
A new clinical practice update outlines a stepwise approach to diagnosing and managing refractory constipation before ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback